Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer
PaperCitations, authors & open-access status
Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 12 citations, 2019 year and closed oa status.
12
Citations
2019
Year
closed
OA Status